#Wegovy #NovoNordisk #ObesityTreatment
www.nasdaq.com
FDA Approves Novo Nordisk's Higher-Dose Wegovy for Obesity Patients
Novo Nordisk NVO announced that the FDA has approved Wegovy HD (once-weekly injectable semaglutide 7. 2 mg) to reduce excess body weight and maintain weight reduction in the long term.